Your browser doesn't support javascript.
loading
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth.
Kamposioras, Konstantinos; Mauri, Davide; Papadimitriou, Konstantinos; Anthoney, Alan; Hindi, Nadia; Petricevic, Branka; Dambrosio, Mario; Valachis, Antonis; Kountourakis, Pantelis; Kopecky, Jindrich; Kuhar, Cvetka Grasic; Popovic, Lazar; Chilingirova, Nataliya P; Zarkavelis, George; de Mello, Ramon Andrade; Plavetic, Natalija Dedic; Christopoulos, Christos; Mostert, Bianca; Goffin, John R; Tzachanis, Dimitiros; Saraireh, Haytham Hamed; Ma, Fei; Pavese, Ida; Tolia, Maria.
Afiliación
  • Kamposioras K; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Mauri D; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
  • Papadimitriou K; Early Clinical Trials Unit, Antwerp University Hospital, Antwerp, Belgium.
  • Anthoney A; Leeds Institute of Medical Research at St James' Hospital, University of Leeds, Leeds, United Kingdom.
  • Hindi N; Department of Medical Oncology, University Hospital Virgen del Rocío, Sevilla, Spain.
  • Petricevic B; TERABIS Group, IBiS (Instituto de Biomedicina de Sevilla)/HUVR/CSIC/Universidad deSevilla), Sevilla, Spain.
  • Dambrosio M; Medizinische Abteilung, Zentrum für Onkologie und Hämatologie mit Ambulanz und alliativstation Wilhelminenspital, Vienna, Austria.
  • Valachis A; Department of Clinical Oncology, Clinica San Carlo, Milan, Italy.
  • Kountourakis P; Department of Oncology, Faculty of Medicine & Health, Örebro University, Örebro, Sweden.
  • Kopecky J; Medical Oncology Department, Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
  • Kuhar CG; Department of Clinical Oncology, University Hospital, Charles University-Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czechia.
  • Popovic L; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
  • Chilingirova NP; Oncology Institute of Vojvodina, University of Novi Sad, Novi Sad, Serbia.
  • Zarkavelis G; University Specialized Hospital for Active Treatment in Oncology, Medical Oncology Clinic, Sofia, Bulgaria.
  • de Mello RA; Medical University Pleven, Pleven, Bulgaria.
  • Plavetic ND; Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece.
  • Christopoulos C; Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.
  • Mostert B; Department of Biomedical Sciences and Medicine, University of Algarve, Faro, Portugal.
  • Goffin JR; University Hospital Centre, Zagreb Department of Oncology, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Tzachanis D; Service de Radiothérapie Oncologique, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France.
  • Saraireh HH; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
  • Ma F; Department of Oncology, McMaster University Juravinski Cancer Centre, Hamilton, ON, Canada.
  • Pavese I; Department of Medicine, University of California San Diego School of Medicine, La Jolla, CA, United States.
  • Tolia M; Radiation Oncology Department, Jordanian Royal Medical Services, Amman, Jordan.
Front Oncol ; 10: 575148, 2020.
Article en En | MEDLINE | ID: mdl-33330049
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido